Speaking Faculty

Rick Doblin, Ph.D.
Rick Doblin, Ph.D.Founder & Executive Director
Multidisciplinary Association of Psychedelic Studies (MAPS)
Charles Nichols, Ph.D.
Charles Nichols, Ph.D.Prof., Dept. of Pharmacology & Experimental Therapeutics
LSU Health Sciences Center
Frederick Barrett, Ph.D.
Frederick Barrett, Ph.D.Assistant Professor of Psychiatry & Behavioral Sciences
Johns Hopkins School of Medicine
Bryan Roth, MD, Ph.D.
Bryan Roth, MD, Ph.D.Michael Hooker Distinguished Professor
U. of North Carolina School of Medicine
Javier Gonzalez Maeso, Ph.D.
Javier Gonzalez Maeso, Ph.D.Professor of Physiology and Biophysics
VCU School of Medicine
Alan Kozikowski, Ph.D.
Alan Kozikowski, Ph.D.Chief Scientific Officer
Bright Minds
Henri Sant-Cassia
Henri Sant-CassiaFounding Partner
The Conscious Fund
JR Rahn
JR RahnCo-Founder,


Boris Heifets, MD, Ph.D.
Boris Heifets, MD, Ph.D.Assistant Professor, Dept. of Anesthesiology, Perioperative & Pain Medicine
Stanford University School of Medicine
Neiloufar Family, Ph.D.
Neiloufar Family, Ph.D.Psychiatric Research Director
Stephen Ross, MD
Stephen Ross, MDAssociate Director
NYU Langone Health Center for Psychedelic Medicine
Shlomi Raz
Shlomi RazChief Executive Officer
Jesper Langgaard Kristensen, Ph.D.
Jesper Langgaard Kristensen, Ph.D.Prof., Medicinal Chemistry, Dept. of Drug Design & Pharmacology/Chief Scientific Officer
University of Copenhagen/Lophora
Judy Ashworth, MD
Judy Ashworth, MDVice President, Rx Strategic Services and Chief Medical Officer
Pinney Associates
Marion Coe, Ph.D.
Marion Coe, Ph.D.Scientist
Pinney Associates
Timothy Ko
Timothy KoChief Executive Officer
Entheon Biomedical
Tristan McClure-Begley, Ph.D.
Tristan McClure-Begley, Ph.D.Program Manager, Focused Pharma
Defense Advanced Research Projects Agency (DARPA)
Revati Shreeniwas, MD
Revati Shreeniwas, MDChief Medical Officer
Bright Minds
Jack Henningfield, Ph.D.
Jack Henningfield, Ph.D.VP, Research, Health Policy, & Abuse Liability
Pinney Associates

The full speaking faculty for this event has not yet been announced. Please check back in the coming days for updates or join our mailing list.